RFL
NYSE · Pharmaceuticals
Rafael Holdings Inc-Class B
$1.04
-0.02 (-1.89%)
Open$1.05
Previous Close$1.06
Day High$1.10
Day Low$0.99
52W High$3.96
52W Low$0.99
Volume—
Avg Volume79.4K
Market Cap53.50M
P/E Ratio—
EPS$-0.68
SectorPharmaceuticals
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.58M | 1.21M | 15.20M |
| Net Income | -52,605,683 | -36,202,106 | 4.84M |
| Profit Margin | -3,328.2% | -3,161.8% | 31.9% |
| EBITDA | -49,766,026 | -36,150,577 | 7.34M |
| Free Cash Flow | — | — | 4.44M |
| Rev Growth | +30.8% | +30.8% | +5.7% |
| Debt/Equity | 0.01 | 0.01 | 0.33 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |